Sale!

Acetylcholine Receptor ACHR Blocking Antibody Test Cost

Original price was: 2,600 د.إ.Current price is: 2,000 د.إ.

-23%

The Acetylcholine Receptor (AChR) Blocking Antibody Test is a specialized diagnostic procedure aimed at detecting antibodies that may interfere with the normal functioning of acetylcholine receptors. These receptors are crucial for muscle contraction and play a significant role in various neuromuscular junctions. The presence of blocking antibodies can lead to conditions such as Myasthenia Gravis, an autoimmune disorder characterized by weakness and fatigue of skeletal muscles. This test is particularly useful for diagnosing and managing this condition, offering insights into the severity of the immune response and guiding treatment strategies.

The test is conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic services and precise testing methodologies. The cost of the AChR Blocking Antibody Test is set at 2000 AED. This investment covers the sophisticated techniques and expertise required to accurately detect and quantify the presence of these specific antibodies. Patients or healthcare providers looking for comprehensive and reliable diagnostic services in the region can consider DNA Labs UAE as a trusted partner in healthcare management, especially for conditions related to neuromuscular disorders.

Description

ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY Test

Cost: AED 2000.0

Symptoms, Diagnosis, and Test Details:

The ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY test is a laboratory test used to detect the presence of antibodies that block acetylcholine receptors (AChR) in the body. These antibodies are typically found in individuals with autoimmune conditions such as myasthenia gravis (MG). Myasthenia gravis is a neuromuscular disorder characterized by muscle weakness and fatigue.

It occurs when the immune system mistakenly attacks AChR, which are proteins located on the surface of muscle cells. Antibodies that block AChR can interfere with the normal transmission of nerve signals to the muscles, leading to muscle weakness.

The ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY test involves collecting a blood sample from the individual and testing it for the presence of these antibodies. The test is typically performed using a technique called radioimmunoassay or enzyme-linked immunosorbent assay (ELISA). These tests can detect and measure the levels of AChR blocking antibodies in the blood.

A positive result on the ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY test indicates the presence of these antibodies and suggests a diagnosis of myasthenia gravis. However, it is important to note that not all individuals with myasthenia gravis will test positive for AChR blocking antibodies. In some cases, other antibodies, such as anti-MuSK antibodies, may be responsible for the condition.

The ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY test is often used in conjunction with other diagnostic tests, such as electromyography (EMG) and a physical examination, to confirm a diagnosis of myasthenia gravis. It can also be used to monitor the effectiveness of treatment and assess disease progression.

Overall, the ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY test plays a crucial role in the diagnosis and management of myasthenia gravis, helping healthcare professionals make informed treatment decisions for individuals with this condition.

For more information or to schedule a test, please contact DNA Labs UAE.

Test Name	ACETYLCHOLINE RECEPTOR ACHR BLOCKING ANTIBODY Test
Components
Price	2000.0 AED
Sample Condition	2 mL (0.5 mL min.) serum from 1 Red Top (No Additive) tube. Do not use SST gel barrier tubes. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery	2-3 weeks
Method	Radioimmunoassay
Test type	Myasthenia Gravis
Doctor	Physician, Neurologist
Test Department:	OS
Pre Test Information	Duly filled Test Send Out Consent Formis mandatory.
Test Details	The AChR blocking antibody test is a laboratory test used to detect the presence of antibodies that block acetylcholine receptors (AChR) in the body. These antibodies are typically found in individuals with autoimmune conditions such as myasthenia gravis (MG). Myasthenia gravis is a neuromuscular disorder characterized by muscle weakness and fatigue. It occurs when the immune system mistakenly attacks AChR, which are proteins located on the surface of muscle cells. Antibodies that block AChR can interfere with the normal transmission of nerve signals to the muscles, leading to muscle weakness. The AChR blocking antibody test involves collecting a blood sample from the individual and testing it for the presence of these antibodies. The test is typically performed using a technique called radioimmunoassay or enzyme-linked immunosorbent assay (ELISA). These tests can detect and measure the levels of AChR blocking antibodies in the blood. A positive result on the AChR blocking antibody test indicates the presence of these antibodies and suggests a diagnosis of myasthenia gravis. However, it is important to note that not all individuals with myasthenia gravis will test positive for AChR blocking antibodies. In some cases, other antibodies, such as anti-MuSK antibodies, may be responsible for the condition. The AChR blocking antibody test is often used in conjunction with other diagnostic tests, such as electromyography (EMG) and a physical examination, to confirm a diagnosis of myasthenia gravis. It can also be used to monitor the effectiveness of treatment and assess disease progression. Overall, the AChR blocking antibody test plays a crucial role in the diagnosis and management of myasthenia gravis, helping healthcare professionals make informed treatment decisions for individuals with this condition.